Clinical Trial Update: Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating bivalirudin in elderly patients undergoing elective percutaneous coronary intervention; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aging
• Coronary Syndrome
• Percutaneous Coronary Intervention

Drugs mentioned

• Bivalirudin (bivalirudin)

Snippet

Sponsor: The First Affiliated Hospital of Dalian Medical University | Conditions: Acute Coronary Syndrome, Percutaneous Coronary Intervention | Phase 4 | Status: UNKNOWN